Reason for request
Renouvellement d'inscription
Clinical Benefit
| Moderate |
la Commission considère que le service médical rendu par CROMABAK 20 mg/ml, collyre en solution et CROMADOSES 2 %, collyre en solution en récipient unidose reste modéré dans l’indication de l’AMM.
|
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
XpbusqZGvc3qWKML